FDA clears AstraZeneca’s lung cancer immunotherapy – PharmaLive (press release)
Nasdaq |
FDA clears AstraZeneca's lung cancer immunotherapy
PharmaLive (press release) (Reuters) – The U.S. Food and Drug Administration on Friday granted approval for expanded use of AstraZeneca Plc's, immunotherapy drug, Imfinzi, to treat non-small cell lung cancer whose tumors can't be surgically removed. The approval was based on a … U.S. FDA approves AstraZeneca's immunotherapy for lung cancer … US FDA approves AstraZeneca's immunotherapy for lung cancer |
